Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022

SELL
$35.61 - $76.23 $2,670 - $5,717
-75 Reduced 1.28%
5,765 $227,000
Q4 2021

Feb 04, 2022

SELL
$72.5 - $100.68 $14,935 - $20,740
-206 Reduced 3.41%
5,840 $458,000
Q3 2021

Nov 02, 2021

BUY
$90.24 - $124.05 $61,814 - $84,974
685 Added 12.78%
6,046 $582,000
Q1 2021

May 03, 2021

BUY
$116.57 - $155.01 $409,860 - $545,015
3,516 Added 190.57%
5,361 $706,000
Q4 2020

Jan 27, 2021

BUY
$99.61 - $142.12 $183,780 - $262,211
1,845 New
1,845 $269,000
Q3 2019

Nov 14, 2019

SELL
$90.37 - $122.49 $166,732 - $225,994
-1,845 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$89.51 - $118.04 $165,145 - $217,783
1,845 New
1,845 $218,000
Q4 2017

Feb 12, 2018

SELL
$46.49 - $60.51 $318,084 - $414,009
-6,842 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$37.05 - $47.12 $253,496 - $322,395
6,842
6,842 $0

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Alpha Star Capital Management, LLC Portfolio

Follow Alpha Star Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Star Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Star Capital Management, LLC with notifications on news.